Leap Therapeutics, Inc. (LPTX) formed inverse H&S with $7.06 target or 8.00% above today’s $6.54 share price. Leap Therapeutics, Inc. (LPTX) has $80.80 million valuation. The stock increased 2.19% or $0.14 during the last trading session, reaching $6.54. About 34,543 shares traded. Leap Therapeutics, Inc. (NASDAQ:LPTX) has 0.00% since March 5, 2017 and is . It has underperformed by 16.70% the S&P500.
The stock decreased 0.50% or $0.08 during the last trading session, reaching $15.79. About 140,007 shares traded. Blackstone/GSO Strategic Credit Fund (BGB) has risen 17.77% since March 5, 2017 and is uptrending. It has outperformed by 1.07% the S&P500.
Oak Hill Advisors Lp holds 16.73% of its portfolio in Blackstone/GSO Strategic Credit Fund for 1.23 million shares. Robinson Capital Management Llc owns 210,908 shares or 1.51% of their US portfolio. Moreover, Selway Asset Management has 0.96% invested in the company for 104,025 shares. The Illinois-based Rivernorth Capital Management Llc has invested 0.94% in the stock. Vident Investment Advisory Llc, a Georgia-based fund reported 516,354 shares.